Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
· insight molecular diagnostics inc.
AI Briefing
- A new study confirms the effectiveness of iMDx's GraftAssure Assay's proprietary dd-cfDNA combination model score.
- The study's findings suggest a superior performance of the GraftAssure assay technology.
- The results support iMDx's GraftAssure assay as a reliable solution for graft assessment.
Advertisement